Yi Wang

Dr. Yi Wang


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Biological Psychiatry
Verified
Journal Article
Closed access
SCStacy A. Castner
Stacy A. Castner
GSGennady N. Smagin
Gennady N. Smagin
TPTimothy M. Piser
Timothy M. Piser
YWYi Wang
Yi Wang
JSJeffrey S Smith
Jeffrey S Smith
GWGraham V. Williams
Graham V. Williams

1 August 2021 in Food Chemistry
Verified
Journal Article
Closed access
JLJun-Yu Liu
Jun-Yu Liu
DHDong He
Dong He
YXYi-Fan Xing
Yi-Fan Xing
WZWen Zeng
Wen Zeng
KRKai Ren
Kai Ren
Xin-Hui XingXin-Hui Xing
Xin-Hui Xing

26 July 2024 in Science Advances
Verified
Journal Article
Open access
LHLong Huang
Long Huang
WHWei Hu
Wei Hu
LHLong Qun Huang
Long Qun Huang
QZQin Xuan Zhou
Qin Xuan Zhou
ZSZheng Yang Song
Zheng Yang Song
Xin-Hui XingXin-Hui Xing
Xin-Hui Xing
Designing highly efficient orally administrated nanotherapeutics with specific inflammatory site–targeting functions in the gastrointestinal tract for ulcerative colitis (UC) management is a noteworthy challenge. Here, we focused on exploring a specific targeting oral nanotherapy, serving as “one stone,” for the directed localization of inflammation and the regulation of redox homeostasis, thereby achieving effects against “two birds” for UC treatment. Our designed nanotherapeutic agent OPNs@LMWH (oxidation-sensitive ε-polylysine nanoparticles at low–molecular weight heparin) exhibited specific active targeting effects and therapeutic efficacy simultaneously. Our results indicate that OPNs@LMWH had high integrin αM–mediated immune cellular uptake efficiency and preferentially accumulated in inflamed tissues. We also confirmed its effectiveness in the treatment experiment of colitis in mice by ameliorating oxidative stress and inhibiting the activation of inflammation-associated signaling pathways while simultaneously bolstering the protective mechanisms of the colonic epithelium. Overall, these findings underscore the compelling dual functionalities of OPNs@LMWH, which enable effective oral delivery to inflamed sites, thereby facilitating precise UC management.

1 January 2022 in Carbohydrate Polymers
Verified
Journal Article
Closed access
RWRuiyun Wu
Ruiyun Wu
PLPinglan Li
Pinglan Li
YWYi Wang
Yi Wang
NSNan Su
Nan Su
MXMengyuan Xiao
Mengyuan Xiao
NSNan Shang
Nan Shang

6 May 2013 in Asian Journal of Andrology
Verified
Journal Article
Open access
LCLi Chu
Li Chu
WMWei Mao
Wei Mao
KVKim Curran Vikramsingh
Kim Curran Vikramsingh
XLXi Liu
Xi Liu
HQHui-Min Qiu
Hui-Min Qiu
QXQing Xu
Qing Xu
AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology.

3 March 2022 in Frontiers in Nutrition
Verified
Journal Article
Open access
SFSufang Fan
Sufang Fan
JMJunmei Ma
Junmei Ma
CLChunsheng Li
Chunsheng Li
YWYanbo Wang
Yanbo Wang
WZWen Zeng
Wen Zeng
YZYan Zhang
Yan Zhang
A UPLC-MS/MS method was developed for the detection of tropomyosin (TM) in shrimp and crab. After simple extraction, the samples were purified by immunoaffinity column and then digested by trypsin. The obtained sample was separated by Easy-nLC 1000-Q Exactive. The obtained spectrums were analyzed by Thermo Proteome Discoverer 1.4 software and then ANIQLVEK with high sensitivity was selected as the quantitative signature peptide. Isotope-labeled internal standard was used in the quantitative analysis. The method showed good linearity in the range of 5–5,000 μg/L with a limit of quantification (LOQ) of 0.1 mg/kg. The average recoveries were 77.22–95.66% with RSDs ≤ 9.97%, and the matrix effects were between 88.53 and 112.60%. This method could be used for rapid screening and quantitative analysis of TM in shrimp and crab. Thus, it could provide technical support for self-testing of TM by food manufacturers and promote further improvement of allergen labeling in China.